HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions
Official URL: http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-g2-de18 | Version: 0.1.0 | |||
Draft as of 2024-08-12 | Computable Name: TenofovirAlafenamideTAF25mgOrderCodes | |||
Copyright/Legal: Copyright National Association of Community Health Centers, Inc. (NACHC) |
Codes representing possible values for the Tenofovir Alafenamide (TAF) 25 mg Order element
References
Generated Narrative: ValueSet nachc-g2-de18
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
1741729 | tenofovir alafenamide 25 MG |
1858261 | tenofovir alafenamide 25 MG Oral Tablet |
1858263 | tenofovir alafenamide 25 MG [Vemlidy] |
1858267 | tenofovir alafenamide 25 MG Oral Tablet [Vemlidy] |
Generated Narrative: ValueSet
Expansion based on codesystem RxNorm version??rx1
This value set contains 4 concepts
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |